跳至主要内容
临床试验/DRKS00013012
DRKS00013012已完成未知

Selective depletion of the C-reactive protein by means of therapeutic CRP apheresis to reduce myocardial damage after coronary bypass surgery - CABY1

Pentracor GmbH0 个研究点目标入组 44 人开始时间: 2017年9月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 79 Years(—)
性别
All

入选标准

  • elective, isolated, primary coronary bypass surgery
  • 3-fold CHD with or without main stem stenosis
  • Obtained LVEF (> 30%, trans-oesophageal echocardiography (TEE) or angiography)
  • Heart-lung machine (HLM) (two-stage cannulation)
  • Antegrade Bretschneider cardioplegia
  • Mild hypothermia (32 C °)
  • Standard anesthesia (isoflurane)
  • Intraoperative standard protocol (complete heparinization with ACT > 400 s, tranexamic acid, protamine)
  • Postoperative standard protocol (500 mg ASA after 2 h, low dose heparinization after 4 h)
  • written informed consent
  • legal capacity

排除标准

  • Preoperatively
  • Age <18 = 80 years
  • PCI (within the last 2 weeks)
  • Renal insufficiency (creatinine > 1.3 mmol / L)
  • Combination interventions
  • Reoperation
  • Emergency or urgent surgery indication
  • Acute coronary syndrome (IAP, NSTEMI, STEMI)
  • Preoperatively positive hs-troponin I > 40 ng / ml
  • Chronic atrial fibrillation
  • Acute infectious disease (body temperature (auricular, sublingual) > 38.0 °C)
  • Systolic blood pressure < 100 mmHg
  • Known hypersensitivity to therapeutic aphereses
  • Cardiac shock
  • Renal insufficiency requiring dialysis (see above)
  • Pregnancy or lactation
  • Participation in other interventional trial
  • During surgery:
  • Radialis removal
  • Coronary TEA (thrombendarteriectomy)
  • Off-pump
  • Hemofiltration
  • Combination intervention (e.g., mitral valve reconstruction (MKR), LAA (Left Auriculus Atrii))
  • Maze procedure
  • Bypass low-flow closure, ECG changes
  • Antithrombotic therapy (intraoperative clopidogrel and / or aspirin)
  • Second HLM
  • Second cardioplegic cardiac arrest
  • Intraaortal balloon pumping / balloon pulsation (IABP)
  • Extracorporeal membrane oxygenation (ECMO)

研究者

发起方
Pentracor GmbH

相似试验